4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0000950170-25-063792
EVP and Chief Medical Officer sold 762 shares at an average $37.93 ($28,901)
From the SEC's structured data for this filing
Trades in this filing
Crombez Eric · EVP and Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-04-21 | Sale : show line 1 in the form | −242 | $35.11 | $8,497 | 71,680 | D |
| 2025-05-05 | Sale : show line 2 in the form | −520 | $39.24 | $20,405 | 71,530 | D |
| Open-market sales · 762 sh · avg $37.93 · $28,901 | ||||||
Loading xslF345X05/ownership.xml…